Adage Capital Partners’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,456,023
| Closed | -$18.2M | – | 1129 |
|
|
2021
Q3 | $18.2M | Buy |
2,456,023
+28,000
| +1% | +$208K | 0.04% | 489 |
|
|
2021
Q2 | $16.5M | Hold |
2,428,023
| – | – | 0.03% | 542 |
|
|
2021
Q1 | $24.9M | Buy |
2,428,023
+956,023
| +65% | +$9.82M | 0.05% | 375 |
|
|
2020
Q4 | $10.3M | Buy |
1,472,000
+1,368,624
| +1,324% | +$9.58M | 0.02% | 583 |
|
|
2020
Q3 | $844K | Buy |
+103,376
| New | +$844K | ﹤0.01% | 728 |
|